Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03353649 · ClinicalTrials.gov registry record · NA
Applying Novel Technologies and Methods to Inform the Ontology of Self-Regulation: Binge Eating and Smoking
A NA study of Behavior and Smoking, Tobacco, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
- 1
- Study location
NCT03353649: Completed NA study of Behavior and Smoking, Tobacco, sponsored by Stanford University.
NCT03353649 is a NA study of Behavior and Smoking, Tobacco that has completed, run by Stanford University. The registered enrollment target is 115 participants, below the 4,860-participant average among 23 other Behavior trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03353649, a NA study of Behavior and Smoking, Tobacco, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to examine targets of self-regulatory function among two exemplar populations for which behavior plays a critical role in health outcomes: smokers and individual who binge eat (BED). This is the second phase of a study that aims to identify putative mechanisms of behavior change to develop an overarching "ontology" of self-regulatory processes.
Primary Outcome
Interaction of stimulus class, which is the stimulus of value (smoking stimuli for smokers and palatable foods for binge eaters) vs. neutral control stimuli, with the cue, which is the now vs. later cue. The degree to which subjects can regulate their desire to consume their stimulus of value after a later cue is evidence of successful self regulation.
Conditions Studied
Interventions
- DEVICE fMRI
- BEHAVIORAL Now vs. Later Cue
Study Locations (1)
California
- Stanford CNI - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2017-12-08 |
| Est. Completion | 2018-01-14 |
| Phase | NA |
What the finished NCT03353649 record still lists
NCT03353649 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 4,860-participant average among 23 other Behavior trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Behavior appearing as the primary indexed condition, and to 2 interventions - of which fMRI is the first listed.
NCT03353649 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03353649 about?
NCT03353649 is a clinical study titled "Applying Novel Technologies and Methods to Inform the Ontology of Self-Regulation: Binge Eating and Smoking". This study aims to examine targets of self-regulatory function among two exemplar populations for which behavior plays a critical role in health outcomes: smokers and individual who binge eat (BED). This is the second phase of a study that aims to identify putative mechanisms of behavior change to d...
What is the current status of trial NCT03353649?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2017-12-08. Estimated completion is 2018-01-14.
What conditions does trial NCT03353649 study?
This clinical trial studies the following conditions: Behavior, Smoking, Tobacco, Binge Eating.
What interventions are being tested in trial NCT03353649?
The interventions under investigation include: fMRI (DEVICE), Now vs. Later Cue (BEHAVIORAL).
Who is sponsoring clinical trial NCT03353649?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03353649 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03353649's enrollment target sits among peer trials
115 13th of 23 higher than 11 of 23 other Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Therapy Dogs on Child Anxiety and Behavior During Local Anesthesia for Dental Procedures
RECRUITING · NA
-
Socialization To Enrich Participation & Support Sexuality for Young People With I/DD
RECRUITING · NA
-
Pilot Trial of the RUBI Program for Autistic Adults
RECRUITING · NA
-
Studies of Human Inference Using On-line Testing
RECRUITING · NA
-
The VESPA Pilot Study
RECRUITING · NA
-
Modulating Reward Learning Using Transcranial Magnetic Stimulation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI